Vitamin D receptor: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 24: | Line 24: | ||
[[Category:Nuclear receptors]] | [[Category:Nuclear receptors]] | ||
[[Category:Vitamin D]] | [[Category:Vitamin D]] | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 02:40, 18 March 2025
Vitamin D receptor (VDR) is a member of the nuclear receptor family of transcription factors. Upon activation by vitamin D, the VDR forms a heterodimer with the retinoid-X receptor and binds to hormone response elements on DNA resulting in expression or transrepression of specific gene products.
Function[edit]
The VDR is involved in cell proliferation and differentiation. Vitamin D and its analogs modulate a variety of biological responses, inhibiting the growth of malignant cells, modulating the immune response, and regulating differentiation of normal and malignant cells. The VDR is expressed in a large number of tissues including the bone, intestine, kidney, colon, brain cells, immune cells, and breast tissue.
Structure[edit]
The VDR belongs to the family of trans-acting transcriptional regulatory factors. The receptor has a DNA-binding domain (DBD), and a ligand binding domain (LBD). The DBD is highly conserved among the various nuclear receptors, while the LBD is more specific, defining the individuality of each receptor.
Clinical significance[edit]
Mutations in the VDR gene are associated with rickets, a disease caused by vitamin D deficiency. In addition, polymorphisms in the VDR gene have been linked to an increased risk of autoimmune diseases, including type 1 diabetes, multiple sclerosis, and rheumatoid arthritis.
See also[edit]
References[edit]
<references />
